The investigators prepared a novel tranexamic acid (TXA) study designed to estimate the
quantity of blood loss in patients undergoing breast esthetic surgery. This study aims to
quantify blood loss during abdominoplasty with and without TXA. The central hypothesis is
that TXA administration reduces blood loss and fibrinolysis in breast esthetic surgery
patients.